Orchid Pharma receives DCGI approval for Cefepime-Enmetazobactam antibiotic combo in India.
Orchid Pharma receives DCGI approval for new antibiotic drug combo, Cefepime and Enmetazobactam. The company is the first to develop and produce such a drug combination in India. It aims to enhance treatment options for serious infections, targeting conditions like complicated urinary tract infections, acute pyelonephritis, hospital-acquired pneumonia, and ventilator-associated pneumonia.
June 06, 2024
3 Articles